ToxStrategies has exciting news from the FDA Center for Veterinary Medicine!
The Center for Veterinary Medicine (CVM) is paving the way for innovation in the animal feed industry! In a recent Letter to Industry,… read more
Latest News
Final Rule on reporting and recordkeeping requirements for PFAS
The US Environmental Protection Agency (EPA) has issued a final rule on reporting and recordkeeping requirements for per- and polyfluoroalkyl substances (PFAS) through… read more
ToxStrategies Welcomes Brent Finley, Ph.D., DABT
ToxStrategies is pleased to announce that nationally recognized toxicologist Dr. Brent Finley has joined our firm as an Executive Vice President. Dr. Finley… read more
EpidStrategies Supports Neuralace Medical Submission for FDA Approval of Axon Therapy
Neuralace Medical recently received FDA clearance of Axon Therapy for diabetic patients suffering from chronic painful neuropathy. The EpidStrategies medical device trials team… read more
HEORStrategies’ Dr. Naomi Sacks is a Co-Author on a Study of Trends in Myasthenia Gravis Hospitalizations and Mortality
Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study on myasthenia gravis (MG) just published in the journal Neurology. MG… read more
ToxStrategies’ Scientists Publish Data Supporting Safety of Dietary Nitrate in Pigs
ToxStrategies’ scientists Amy Sheppard and Jennifer van de Ligt collaborated with a team of industry scientists from Cargill to evaluate the safety of… read more
ToxStrategies at IPPE 2024 – Atlanta, GA (Booth #A215)
ToxStrategies will be attending and exhibiting at the International Production & Processing Expo (IPPE) in Atlanta, GA from January 30 to February 1,… read more
EPA Begins TSCA Prioritization Process for Five Chemicals
The US Environmental Protection Agency (EPA) has announced that it is beginning the 12-month process to prioritize five additional chemicals for risk evaluation… read more